The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 27, 2017

Filed:

May. 14, 2013
Applicants:

Xin Ji, Shanghai, CN;

Cheng Xing, Shanghai, CN;

Xueshen Shi, Shanghai, CN;

Jianping Chen, Shanghai, CN;

Inventors:

Xin Ji, Shanghai, CN;

Cheng Xing, Shanghai, CN;

Xueshen Shi, Shanghai, CN;

Jianping Chen, Shanghai, CN;

Assignee:

Other;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/718 (2006.01); A61L 24/00 (2006.01); A61L 26/00 (2006.01); A61K 9/14 (2006.01); C08L 3/18 (2006.01); C08L 3/04 (2006.01); C08L 89/06 (2006.01); C08B 31/12 (2006.01); C08B 31/08 (2006.01); C08B 31/02 (2006.01); C08B 33/04 (2006.01); C08B 31/10 (2006.01); C08B 31/16 (2006.01); C08B 35/02 (2006.01); C08B 33/06 (2006.01); C08B 35/06 (2006.01); C08B 35/04 (2006.01); C08B 33/02 (2006.01); C08B 31/04 (2006.01); C08B 30/20 (2006.01); C08B 31/00 (2006.01); C08B 30/00 (2006.01); A61K 31/738 (2006.01); A61L 24/08 (2006.01); A61K 45/06 (2006.01); A61K 9/19 (2006.01); C08B 31/06 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/718 (2013.01); A61K 9/14 (2013.01); A61K 9/19 (2013.01); A61K 31/738 (2013.01); A61K 45/06 (2013.01); A61L 24/0036 (2013.01); A61L 24/08 (2013.01); A61L 26/0023 (2013.01); A61L 26/0085 (2013.01); C08B 30/00 (2013.01); C08B 30/20 (2013.01); C08B 31/00 (2013.01); C08B 31/003 (2013.01); C08B 31/02 (2013.01); C08B 31/04 (2013.01); C08B 31/08 (2013.01); C08B 31/10 (2013.01); C08B 31/12 (2013.01); C08B 31/16 (2013.01); C08B 33/02 (2013.01); C08B 33/04 (2013.01); C08B 33/06 (2013.01); C08B 35/02 (2013.01); C08B 35/04 (2013.01); C08B 35/06 (2013.01); C08L 3/04 (2013.01); C08L 3/18 (2013.01); C08L 89/06 (2013.01); A61K 9/0014 (2013.01); A61L 2400/04 (2013.01); A61L 2430/34 (2013.01); Y10T 428/2982 (2015.01);
Abstract

A modified starch material is arranged for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.


Find Patent Forward Citations

Loading…